Willis Towers Watson had its Relative Strength (RS) Rating upgraded from 70 to 79 Friday — a welcome improvement, but still below the 80 or higher score you prefer to see.
IBD's unique RS Rating measures market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the trailing 52 weeks compares to the rest of the market.
Over 100 years of market history shows that the best-performing stocks tend to have an RS Rating north of 80 as they launch their biggest runs. See if Willis Towers Watson can continue to show renewed price strength and clear that threshold.
Can You Really Time The Stock Market?
Willis Towers Watson is now considered extended and out of buy range after clearing a 269.98 buy point in a first-stage saucer with handle. See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.
In terms of top and bottom line numbers, the company has posted rising EPS growth over the last two quarters. Revenue gains have also increased over the same time frame.
Willis Towers Watson holds the No. 1 rank among its peers in the Insurance-Brokers industry group. Baldwin Insurance Cl A and Ryan Specialty Holdings are also among the group's highest-rated stocks.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
